Assignee
LUBRIS LLC
US·13 granted patents·7 pending applications·61 citations·filing 2014–2025
Top patents by PatentIndex Score
20 records- 0197US10960047B2Compositions and methods for inhibiting intercellular interactionsLUBRIS LLC·Filed 2019·Granted Mar 30, 2021·6 cites·10 claims
- 0295US10723773B2Recombinant lubricinLUBRIS LLC·Filed 2018·Granted Jul 28, 2020·6 cites·10 claims
- 0394US2026098069A1Production of recombinant lubricinLUBRIS LLC·Filed 2025·Application pending·0 cites
- 0491US10500251B2Compositions and methods for inhibiting intercellular interactionsLUBRIS LLC·Filed 2018·Granted Dec 10, 2019·7 cites·16 claims
- 0591US10125180B2Recombinant lubricin compositionLUBRIS LLC·Filed 2014·Granted Nov 13, 2018·11 cites·9 claims
- 0689US9982027B2Control of rheological properties of mixed hyaluronate/lubricin solutionsLUBRIS LLC·Filed 2014·Granted May 29, 2018·8 cites·7 claims
- 0788US10967048B2Use of PRG4 as an anti-inflammatory agentLUBRIS LLC·Filed 2016·Granted Apr 6, 2021·5 cites·19 claims
- 0887US11485764B2Production of recombinant lubricinLUBRIS LLC·Filed 2020·Granted Nov 1, 2022·1 cites·16 claims
- 0986US12435115B2Production of recombinant lubricinLUBRIS LLC·Filed 2022·Granted Oct 7, 2025·0 cites·18 claims
- 1086US10500250B2Compositions and methods for inhibiting intercellular interactionsLUBRIS LLC·Filed 2014·Granted Dec 10, 2019·6 cites·16 claims
- 1184US10383796B2Application and uses of PRG4 and therapeutic modulation thereofLUBRIS LLC·Filed 2017·Granted Aug 20, 2019·11 cites·18 claims
- 1278US11752194B2Compositions and methods for inhibiting intercellular interactionsLUBRIS LLC·Filed 2021·Granted Sep 12, 2023·0 cites·23 claims
- 1364US11717557B2Use of PRG4 as an anti-inflammatory agentLUBRIS LLC·Filed 2021·Granted Aug 8, 2023·0 cites·15 claims
- 1460US2025282981A1Methods of making polymer filmsLUBRIS LLC·Filed 2023·Application pending·0 cites
- 1559US2021338774A1Prg-4 for treating gout and its symptomsLUBRIS LLC·Filed 2021·Application pending·0 cites
- 1650US2022332839A1Use of prg4 to treat cancerLUBRIS LLC·Filed 2020·Application pending·0 cites
- 1747US11666529B2Use of PRG4 to improve dynamic visual acuity and higher order aberrationsLUBRIS LLC·Filed 2016·Granted Jun 6, 2023·0 cites·18 claims
- 1844US2018161393A1Prg4 for treating gout and its symptomsLUBRIS LLC·Filed 2017·Application pending·0 cites
- 1943US2017312335A1Topical use of prg4 for treatment of allergy and symptoms of inflammationLUBRIS LLC·Filed 2016·Application pending·0 cites
- 2042US2021260167A1Lubricin for use in wound healingLUBRIS LLC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →